These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2052064)

  • 1. Drug promotion and scientific exchange. The role of the clinical investigator.
    Kessler DA
    N Engl J Med; 1991 Jul; 325(3):201-3. PubMed ID: 2052064
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA enlists doctors to help spot misleading drug advertisements.
    Tanne JH
    BMJ; 2010 May; 340():c2594. PubMed ID: 20472679
    [No Abstract]   [Full Text] [Related]  

  • 3. Truth in advertising: FDA approval and the physician's responsibility.
    Knapp RM
    Anesthesiology; 1992 Mar; 76(3):477-8. PubMed ID: 1539866
    [No Abstract]   [Full Text] [Related]  

  • 4. Program seeks to enlist physicians to flag questionable promotion of drugs.
    Mitka M
    JAMA; 2010 Jul; 304(1):28-9. PubMed ID: 20606140
    [No Abstract]   [Full Text] [Related]  

  • 5. Adverse-drug-reaction monitoring.
    Faich GA
    N Engl J Med; 1986 Jun; 314(24):1589-92. PubMed ID: 3713757
    [No Abstract]   [Full Text] [Related]  

  • 6. Pitching doctors.
    Wilkes MS; Shuchman M
    N Y Times Mag; 1989 Nov; ():88, 90, 126, 128-129. PubMed ID: 11650264
    [No Abstract]   [Full Text] [Related]  

  • 7. What's happening with pharmaceuticals? And how will it impact your practice?
    Williams B
    Tenn Med; 2005 May; 98(5):213-6. PubMed ID: 15934528
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 9. Pushing drugs to doctors.
    Consum Rep; 1992 Feb; 57(2):87-94. PubMed ID: 11651202
    [No Abstract]   [Full Text] [Related]  

  • 10. Research provides golden opportunity for physicians. An overview of clinical trials and how to conduct them.
    Nylen RA
    Physician Exec; 2002; 28(1):32-7. PubMed ID: 11806227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct-to-consumer advertising--education or emotion promotion?
    Wolfe SM
    N Engl J Med; 2002 Feb; 346(7):524-6. PubMed ID: 11844857
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring for adverse drug events.
    Kennedy DL; Goldman SA
    Am Fam Physician; 1997 Nov; 56(7):1718, 1721. PubMed ID: 9371003
    [No Abstract]   [Full Text] [Related]  

  • 13. Ripe for revision: reassessing the constitutionality of Food and Drug Administration restrictions on protected speech.
    Gibbs JN; Ferrari PL; Murphy AM;
    Food Drug Law J; 2003; 58(3):331-45. PubMed ID: 14626233
    [No Abstract]   [Full Text] [Related]  

  • 14. Trust the doctor's judgment.
    Borum VF
    Tex Med; 2002 Mar; 98(3):13. PubMed ID: 11915534
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug advertising: is this good medicine?
    Consum Rep; 1996 Jun; 61(6):62-3. PubMed ID: 10182464
    [No Abstract]   [Full Text] [Related]  

  • 16. Scientific paper or political 'white paper'?
    Fisher DW
    Hosp Pract (Off Ed); 1992 Jul; 27(7):13, 16. PubMed ID: 1629259
    [No Abstract]   [Full Text] [Related]  

  • 17. Legal issues concerning the promotion of pharmaceutical products on the internet to consumers.
    Reichertz PS
    Food Drug Law J; 1996; 51(3):355-65. PubMed ID: 11797712
    [No Abstract]   [Full Text] [Related]  

  • 18. [Physicians' influence on the "drug market"].
    Paprocki M
    Pol Tyg Lek; 1982 Jun; 37(19-20):585-7. PubMed ID: 7177953
    [No Abstract]   [Full Text] [Related]  

  • 19. Hiding behind agency discretion: the Food and Drug Administration's personal use drug importation policy.
    Reichertz PS; Friend MS
    Cornell J Law Public Policy; 2000; 9():493-521. PubMed ID: 11067734
    [No Abstract]   [Full Text] [Related]  

  • 20. Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometrician.
    Neely M; Jelliffe R
    J Clin Pharmacol; 2010 Jul; 50(7):842-7. PubMed ID: 20154293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.